Nasdaq:US$17.85 (-0.46) | HKEX:HK$28.20 (-1.15) | AIM:£2.74 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 26 Apr 2025

Targeting KEAP1/NRF2 signaling sensitizes KRAS-driven NSCLC to KRAS inhibitors